T0	Participants 85 128	exudative age-related macular degeneration.
T1	Participants 290 325	choroidal neovascularisation (CNV).
T2	Participants 360 384	eyes with new-onset CNV.
T3	Participants 387 421	total of 56 patients were enrolled
T4	Participants 1665 1685	in patients with CNV